Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$491M |
| 2 |
Microsoft
MSFT
|
+$352M |
| 3 |
Apple
AAPL
|
+$346M |
| 4 |
Janus Henderson Mortgage-Backed Securities ETF
JMBS
|
+$333M |
| 5 |
Cisco
CSCO
|
+$324M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$409M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$374M |
| 3 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$347M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$343M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Financials | 12.41% |
| 3 | Healthcare | 11.8% |
| 4 | Consumer Discretionary | 10.03% |
| 5 | Industrials | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Cerus
CERS
$570M
| $3.58M | ﹤0.01% |
1,656,656
-25,310
| -2% | -$41.7K |
|
2452
Cogent Biosciences
COGT
$6.58B
| $3.56M | ﹤0.01% |
606,029
+13,537
| +2% | +$104K |
|
2453
Energy Fuels
UUUU
$3.6B
| $3.56M | ﹤0.01% |
494,589
+17,749
| +4% | +$137K |
|
|
TWKS
2454
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
| $3.55M | ﹤0.01% |
737,616
+10,213
| +1% | +$41.9K |
|
2455
UBS Group
UBS
$176B
| $3.53M | ﹤0.01% |
114,356
+29,487
| +35% | +$775K |
|
2456
Theravance Biopharma
TBPH
$878M
| $3.53M | ﹤0.01% |
314,011
-14,166
| -4% | -$143K |
|
|
ALX
2457
Alexander's
ALX
$1.41B
| $3.5M | ﹤0.01% |
16,370
-256
| -2% | -$48.4K |
|
2458
Nu Holdings
NU
$66.9B
| $3.49M | ﹤0.01% |
418,958
+29,761
| +8% | +$241K |
|
|
AHT
2459
Ashford Hospitality Trust
AHT
$20.1M
| $3.47M | ﹤0.01% |
178,628
+52,679
| +42% | +$1.16M |
|
|
SPWR
2460
DELISTED
SunPower Corporation Common Stock
SPWR
| $3.45M | ﹤0.01% |
715,102
+34,023
| +5% | +$162K |
|
|
SILK
2461
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $3.45M | ﹤0.01% |
281,217
-16,927
| -6% | -$159K |
|
2462
Playtika
PLTK
$938M
| $3.44M | ﹤0.01% |
394,322
+15,305
| +4% | +$133K |
|
2463
Vital Farms
VITL
$498M
| $3.43M | ﹤0.01% |
218,454
-4,084
| -2% | -$51.7K |
|
2464
Vanguard Information Technology ETF
VGT
$151B
| $3.42M | ﹤0.01% |
56,544
-9,272
| -14% | -$517K |
|
2465
Organogenesis Holdings
ORGO
$233M
| $3.41M | ﹤0.01% |
834,008
+7,516
| +0.9% | +$21K |
|
2466
Coupang
CPNG
$29B
| $3.4M | ﹤0.01% |
209,984
+13,291
| +7% | +$219K |
|
|
AMPS
2467
DELISTED
Altus Power
AMPS
| $3.39M | ﹤0.01% |
496,888
+10,199
| +2% | +$55.2K |
|
2468
Replimune Group
REPL
$1.45B
| $3.39M | ﹤0.01% |
401,942
+23,632
| +6% | +$274K |
|
2469
TSMC
TSM
$2.25T
| $3.38M | ﹤0.01% |
32,475
+25,882
| +393% | +$2.47M |
|
2470
SandRidge Energy
SD
$521M
| $3.36M | ﹤0.01% |
246,147
+4,599
| +2% | +$67.9K |
|
2471
Tootsie Roll Industries
TR
$3.04B
| $3.36M | ﹤0.01% |
110,540
+4,257
| +4% | +$125K |
|
|
HLVX
2472
DELISTED
HilleVax
HLVX
| $3.35M | ﹤0.01% |
208,773
+63,125
| +43% | +$839K |
|
|
STER
2473
DELISTED
Sterling Check Corp. Common Stock
STER
| $3.35M | ﹤0.01% |
240,464
+5,701
| +2% | +$71.6K |
|
2474
ChargePoint
CHPT
$163M
| $3.34M | ﹤0.01% |
71,357
-11,761
| -14% | -$658K |
|
2475
MetroCity Bankshares
MCBS
$1.05B
| $3.33M | ﹤0.01% |
138,749
+450
| +0.3% | +$9.6K |
|
Similar funds
Charles Schwab's Q4 2023 Portfolio in Review
As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
- Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
- Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
- Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
- Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
- Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
- Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.
Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.